ESR1 and breast cancer: Traditionally, histological classification of BC mainly depends on estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, with molecular subtyping improving patient prognosis through hormone therapy [32].